(Total Views: 547)
Posted On: 03/12/2018 9:45:00 PM
Post# of 30066
Mar. 15, 2018 - Two protein-coding genes act as a novel clinical signature to predict prognosis in patients with ovarian serous cystadenocarcinoma.
Cytokinesis 11 and guess the other one?
https://www.ncbi.nlm.nih.gov/pubmed/29456732
It is turning out that not only MANF can potentially be a theraputic solution in so many indications, researchs are also seeing the potential in DX. This is now the 2nd or 3rd we've found.
Bring back the Dx, Where's that OvaDX?
Cytokinesis 11 and guess the other one?
https://www.ncbi.nlm.nih.gov/pubmed/29456732
It is turning out that not only MANF can potentially be a theraputic solution in so many indications, researchs are also seeing the potential in DX. This is now the 2nd or 3rd we've found.
Bring back the Dx, Where's that OvaDX?
(5)
(0)
